AAAAAA
Results: 1-25/30
Authors:
Opal, SM
Sypek, JP
Keith, JC
Schaub, RG
Palardy, JE
Parejo, NA
Citation: Sm. Opal et al., Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection, SHOCK, 15(4), 2001, pp. 285-290
Authors:
Opal, SM
Palardy, JE
Parejo, N
Morrison, DC
Citation: Sm. Opal et al., Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis, J ENDOTOX R, 7(1), 2001, pp. 35-38
Authors:
Warren, BL
Eid, A
Singer, P
Pillay, SS
Carl, P
Novak, I
Chalupa, P
Atherstone, A
Penzes, I
Kubler, A
Knaub, S
Keinecke, HO
Heinrichs, H
Schindel, F
Juers, M
Bone, RC
Opal, SM
Citation: Bl. Warren et al., High-dose a randomized antithrombin III in severe sepsis - A randomized controlled trial, J AM MED A, 286(15), 2001, pp. 1869-1878
Authors:
Opal, SM
Palardy, JE
Parejo, NA
Creasey, AA
Citation: Sm. Opal et al., The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis, CRIT CARE M, 29(1), 2001, pp. 13-17
Authors:
Florquin, S
van den Berg, JG
Olszyna, DP
Claessen, N
Opal, SM
Weening, JJ
van der Poll, T
Citation: S. Florquin et al., Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia, KIDNEY INT, 59(6), 2001, pp. 2054-2061
Authors:
Cross, AS
Opal, SM
Warren, HS
Palardy, JE
Glaser, K
Parejo, NA
Bhattacharjee, AK
Citation: As. Cross et al., Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis, J INFEC DIS, 183(7), 2001, pp. 1079-1086
Authors:
Opal, SM
Citation: Sm. Opal, Protein C levels in severe sepsis, CHEST, 120(3), 2001, pp. 699-701
Authors:
Horn, DL
Morrison, DC
Opal, SM
Silverstein, R
Visvanathan, K
Zabriskie, JB
Citation: Dl. Horn et al., What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium, CLIN INF D, 31(4), 2000, pp. 851-858
Authors:
Opal, SM
Huber, CE
Citation: Sm. Opal et Ce. Huber, The role of interleukin-10 in critical illness, CURR OPIN I, 13(3), 2000, pp. 221-226
Authors:
Opal, SM
Citation: Sm. Opal, The interaction between the coagulation system and the systemic inflammatory mediators, UPD INT CAR, 31, 2000, pp. 280-291
Authors:
Opal, SM
Citation: Sm. Opal, Prospects for a vaccine to prevent bacterial sepsis, UPD INT CAR, 31, 2000, pp. 405-421
Authors:
Opal, SM
Citation: Sm. Opal, Therapeutic rationale for antithrombin III in sepsis, CRIT CARE M, 28(9), 2000, pp. S34-S37
Authors:
Opal, SM
Citation: Sm. Opal, Phylogenetic and functional relationships between coagulation and the innate immune response, CRIT CARE M, 28(9), 2000, pp. S77-S80
Authors:
Opal, SM
Citation: Sm. Opal, Hemofiltration-absorption systems for the treatment of experimental sepsis: Is it possible to remove the "evil humors" responsible for septic shock?, CRIT CARE M, 28(5), 2000, pp. 1681-1682
Authors:
Abraham, E
Matthay, MA
Dinarello, CA
Vincent, JL
Cohen, J
Opal, SM
Glauser, M
Parsons, P
Fisher, CJ
Repine, JE
Citation: E. Abraham et al., Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation, CRIT CARE M, 28(1), 2000, pp. 232-235
Authors:
Olszyna, DP
Opal, SM
Prins, JM
Horn, DL
Speelman, P
van Deventer, SJH
van der Poll, T
Citation: Dp. Olszyna et al., Chemotactic activity of CXC chemokines interleukin-8, growth-related oncogene-alpha, and epithelial cell-derived neutrophil-activating protein-78 in urine of patients with urosepsis, J INFEC DIS, 182(6), 2000, pp. 1731-1737
Authors:
Simpson, AJH
Opal, SM
Angus, BJ
Prins, JM
Palardy, JE
Parejo, NA
Chaowagul, W
White, NJ
Citation: Ajh. Simpson et al., Differential antibiotic-induced endotoxin release in severe melioidosis, J INFEC DIS, 181(3), 2000, pp. 1014-1019
Authors:
Opal, SM
Keith, JC
Palardy, JE
Parejo, N
Citation: Sm. Opal et al., Recombinant human interleukin-11 has anti-inflammatory actions yet does not exacerbate systemic Listeria infection, J INFEC DIS, 181(2), 2000, pp. 754-756
Authors:
Opal, SM
DePalo, VA
Citation: Sm. Opal et Va. Depalo, Anti-inflammatory cytokines, CHEST, 117(4), 2000, pp. 1162-1172
Authors:
Opal, SM
Cross, AS
Citation: Sm. Opal et As. Cross, Clinical trials for severe sepsis - Past failures, and future hopes, INF DIS CL, 13(2), 1999, pp. 285
Authors:
Opal, SM
Cross, AS
Citation: Sm. Opal et As. Cross, Bacterial sepsis and septic shock - Preface, INF DIS CL, 13(2), 1999, pp. XIII-XIV
Authors:
Cross, AS
Opal, SM
Bhattacharjee, AK
Donta, ST
Peduzzi, PN
Furer, E
Que, JU
Cryz, SJ
Citation: As. Cross et al., Immunotherapy of sepsis: flawed concept or faulty implementation?, VACCINE, 17, 1999, pp. S13-S21
Authors:
Opal, SM
Citation: Sm. Opal, Selenium replacement in severe systemic inflammatory response syndrome, CRIT CARE M, 27(9), 1999, pp. 2042-2043
Authors:
Opal, SM
Cohen, J
Citation: Sm. Opal et J. Cohen, Clinical Gram-positive sepsis: Does it fundamentally differ from Gram-negative bacterial sepsis?, CRIT CARE M, 27(8), 1999, pp. 1608-1616
Authors:
Opal, SM
Citation: Sm. Opal, Tumor necrosis factor receptor expression on inflammatory cells in sepsis, CRIT CARE M, 27(2), 1999, pp. 240-241